Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 20;5(1):e11136.
doi: 10.2196/11136.

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

Brian Rice  1 , Andrew Boulle  2 , Sandra Schwarcz  3 , Amir Shroufi  4 , George Rutherford  3 , James Hargreaves  1
Affiliations

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

Brian Rice et al. JMIR Public Health Surveill. .

Abstract

The move toward universal provision of antiretroviral therapy and the expansion of HIV viral load monitoring call into question the ongoing value of CD4 cell count testing and monitoring. We highlight the role CD4 monitoring continues to have in guiding clinical decisions and measuring and evaluating the epidemiology of HIV. To end the HIV/AIDS epidemic, we require strategic information, which includes CD4 cell counts, to make informed clinical decisions and effectively monitor key surveillance indicators.

Keywords: CD4; HIV; antiretroviral therapy; differential care; monitoring; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
ART initiations in Eshowe and Mbongolwane, KwaZulu-Natal, stratified by CD4 count, 2011 to 2017. CD4 counts are measured as CD4 cells/µL. Q1 was from January to end March 2017. ART: antiretroviral therapy.
See this image and copyright information in PMC

References

    1. World Health Organization. 2010. [2019-02-20]. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach - 2010 revision https://www.who.int/hiv/pub/arv/adult2010/en/
    1. World Health Organization. 2015. [2019-02-20]. Guideline on when to start antiretroviral therapyon pre-exposure prophylaxis for HIV https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
    1. Davies M, Ford N, Rabie H, Fatti G, Stinson K, Giddy J, Tanser F, Technau K, Sawry S, Eley B, Wood R, Mofenson LM, Keiser O, Boulle A. Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression. Pediatr Infect Dis J. 2015 Dec;34(12):1361–4. doi: 10.1097/INF.0000000000000912. http://europepmc.org/abstract/MED/26379169 - DOI - PMC - PubMed
    1. Ford N, Stinson K, Davies M, Cox V, Patten G, Cragg C, Van Cutsem Gilles, Boulle Andrew. Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa. AIDS. 2014 Sep 10;28(14):2003–5. doi: 10.1097/QAD.0000000000000406. - DOI - PubMed
    1. Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies M, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK. The future role of CD4 cell count for monitoring antiretroviral therapy. The Lancet Infectious Diseases. 2015 Feb;15(2):241–247. doi: 10.1016/S1473-3099(14)70896-5. - DOI - PubMed